Monthly Archives: April 2018

Netflix Knows No Limits

If anyone ever thought that Netflix (Nasdaq: NFLX) had no room to grow in the US, they are in for a surprise. Earlier this week, Netflix reported its first-quarter results and it delivered stunning subscriber growth, even for the domestic market. Netflix’s Financials Netflix’s Q1 revenues grew 40% over the year to $3.7 billion, marginally…

E

On Saturday night I was treated to a performance at the Richard Rogers Theater of Hamilton. It was weird, with a racially mixed cast all dressed in 18th century costumes and uniforms, singing hip-hop, a musical anachronism. I found myself looking forward to the commentary by George III who periodically appeared in his crimson robe and crown, but I…

Morgan Stanley (MS) Beats Q1 Earnings And Revenue Estimates

Have you been eager to see how Morgan Stanley (MS – Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this New York-based leading financial services holding company’s earnings release this morning: An Earnings Beat Morgan Stanley came out with earnings of $1.45 per share, which surpassed the Zacks…

Stocks Outlook – Wednesday, April 18

Thoughts Housing Starts are still trending higher. Medium-long term bullish for stocks. Deqlinquency rate on subprime auto loans is surging. Not a repeat of 2008. The S&P 500 reclaimed its 50 daily moving average. An irrelevant sign for the stock market. The U.S. stock market is starting to ignore China trade war news. 1 am:…

Stocks: Stop Light

Bonjour, mon ami! Observant readers may have noticed this comment yesterday: I probably don’t need to bother showing you this, but……… As for equities, it occurs to me we can think of this year’s price activity as a stop light. The topping action was up at the green light area, and that terminated late in January….

E

As a value investor, and contrarian, I am attracted to companies, sectors, and industries, that other investors are currently afraid of. This lead me to the Health Care sector and United Therapeutics Corporation (UTHR). At today’s price in the current market conditions, is United Therapeutics going to outperform the market over the next 7-10 years?…